FOCUS DAILIES VISITINT (AQUA RELEASE) CBV92000494

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2019-01-23 for FOCUS DAILIES VISITINT (AQUA RELEASE) CBV92000494 manufactured by Ciba Vision Asian Mfg And Logistics Pte Ltd..

Event Text Entries

[134062779] This investigation was reopened as the actual complaint product was returned. Investigation including root cause analysis is in progress and an update to the manufacturing review has been requested. A supplemental mdr will be filed as necessary in accordance with 21 cfr 803. 56 to update any significant changes. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[134062780] As reported by the patient via telephone on (b)(6) 2018, she felt irritation on (b)(6) 2018 after several hours of use. The patient visited the doctor on (b)(6) 2018 and was diagnosed with several white spots found on cornea and corneal epithelium defect. The eye care provider (ecp) instructed to revisit after two to three days. Unspecified eye drops and eye-ointment were prescribed; treatment modality and duration were not provided. Symptoms were not resolved. Additional information was received on (b)(6) 2018. The patient sought medical attention on (b)(6) 2018 and was prescribed with gatifloxacin ophthalmic eye drops, cefmenoxime hydrochloride and ofloxacin ophthalmic; treatment modality and duration were not provided. The patient did a follow up visit and was prescribed gentamicin sulfate ophthalmic eye drop and an unspecified internal medicine; treatment modality and duration were not provided. The patient was referred to another health care facility during her follow up visit on (b)(6) 2018. On the same day, the patient did another visit and was prescribed with moxifloxacin and cefmenoxime hydrochloride to be applied every hour and tobramycin to be applied six times a day. The patient was also prescribed with an unspecified eye ointment and loxoprofen sodium; treatment modality and duration were not provided. The patient was instructed to suspend lens wear, to return for a follow up visit and to avoid using the contact lens on the left eye. It was confirmed that the event was caused by the lens. The patient's corneal surface was rubbed to perform bacterial exam and to infiltrate medicine effectively. Patient's symptoms was reported as improving. Additional information was received on (b)(6) 2018, the patient revisited the ecp and was scheduled for another follow-up visit on (b)(6) 2018. Additional information was received on (b)(6) 2018 from the consumer. She did a follow up visit with her ecp on (b)(6) 2018 and confirmed that she had infective keratitis. Previously prescribed eye drops were instructed to be continued. Additional information was scheduled to be requested.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3003657720-2019-00001
MDR Report Key8272306
Date Received2019-01-23
Date of Report2019-04-11
Date of Event2018-12-01
Date Mfgr Received2019-03-20
Device Manufacturer Date2018-05-03
Date Added to Maude2019-01-23
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. CINDY MILAM
Manufacturer Street6201 SOUTH FREEWAY MAIL STOP AB2-6
Manufacturer CityFORT WORTH TX 76134
Manufacturer CountryUS
Manufacturer Postal76134
Manufacturer Phone8176152231
Manufacturer G1CIBA VISION ASIAN MFG AND LOGISTICS PTE LTD.
Manufacturer Street133 TUAS SOUTH AVENUE 3
Manufacturer CityTUAS 637550
Manufacturer CountrySN
Manufacturer Postal Code637550
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report0

Device Details

Brand NameFOCUS DAILIES VISITINT (AQUA RELEASE)
Generic NameLENS, CONTACT, (DISPOSABLE)
Product CodeMVN
Date Received2019-01-23
Returned To Mfg2018-12-17
Model NumberNA
Catalog NumberCBV92000494
Lot NumberC0346358
OperatorLAY USER/PATIENT
Device AvailabilityR
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerCIBA VISION ASIAN MFG AND LOGISTICS PTE LTD.
Manufacturer Address133 TUAS SOUTH AVENUE 3 TUAS 637550 SN 637550


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2019-01-23

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.